AQST News

Pomerantz LLP Issues Important Reminder to Investors in Aquestive Therapeutics, Inc. of Class Action – AQST

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losess in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AQST

Pomerantz LLP Issues Important Reminder to Aquestive Therapeutics, Inc. Shareholders – AQST

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit

Pomerantz LLP Issues Important Reminder to Aquestive Therapeutics, Inc. Investors – AQST

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

AQST Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Aquestive Therapeutics, Inc. Securities Class Action Lawsuit — The Gross Law Firm

AQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 USA - English USA - English USA - English Suomi - Suomeksi Norge - Norsk Danmark - Dansk

AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!